Literature DB >> 164130

Arteriographic demonstration of intravenous tumor extension.

F P Gregg, H M Goldstein, S Wallace, J H Casey.   

Abstract

The arteriographic demonstration of a linear, striated arterial pattern in the anatomic course of the draining vein is reliable evidence of venous extension by a tumor and represents the supply to the intravenous component of the neoplasm. In addition to its previously described occurrence with hypernephromas, this report documents the characteristic angiographic appearance with hepatocellular tumors and a retroperitoneal osteosarcoma as reliable evidence of tumor extension into the inferior vena cava. It is possible that in some cases, the parallel arteries represent markedly enlarged vasa vasorum of the involved venous structure. The frequent invasion of the inferior vena cava by hepatomas and the importance of inferior vena cavography in their angiographic evaluation is also emphasized.

Entities:  

Mesh:

Year:  1975        PMID: 164130     DOI: 10.2214/ajr.123.1.100

Source DB:  PubMed          Journal:  Am J Roentgenol Radium Ther Nucl Med        ISSN: 0002-9580


  4 in total

1.  Tumor embolism in the right atrium after hepatic artery ligation for hepatoma.

Authors:  R Kanashima; N Nagasue; M Kobayashi; K Inokuchi
Journal:  Jpn J Surg       Date:  1977-12

Review 2.  Osteosarcoma tumor thrombus: a case report with a review of the literature.

Authors:  Pournima Navalkele; Sarah M Jones; Jason K Jones; Jorge D Salazar; Patrick C Toy; Rathi V Iyer; Betty Herrington
Journal:  Tex Heart Inst J       Date:  2013

Review 3.  Imaging procedures in the detection of cardiac tumors, with emphasis on echocardiography: a review.

Authors:  H G Bogren; A N DeMaria; D T Mason
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

4.  Radiological characteristics and predisposing factors of venous tumor thrombus in pelvic osteosarcoma: A mono-institutional retrospective study of 115 cases.

Authors:  Haijie Liang; Wei Guo; Rongli Yang; Xiaodong Tang; Taiqiang Yan; Tao Ji; Yi Yang; Dasen Li; Lu Xie; Jie Xu
Journal:  Cancer Med       Date:  2018-08-23       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.